Morgan Stanley’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-55,191
Closed -$2.9M 7293
2020
Q3
$2.9M Sell
55,191
-264,636
-83% -$13.9M ﹤0.01% 3295
2020
Q2
$10.6M Buy
319,827
+37,390
+13% +$1.24M ﹤0.01% 1910
2020
Q1
$7.68M Sell
282,437
-239,674
-46% -$6.52M ﹤0.01% 2016
2019
Q4
$10.3M Sell
522,111
-73,101
-12% -$1.44M ﹤0.01% 2411
2019
Q3
$7.71M Buy
595,212
+134,675
+29% +$1.75M ﹤0.01% 2391
2019
Q2
$5.73M Buy
460,537
+403,661
+710% +$5.02M ﹤0.01% 2785
2019
Q1
$826K Sell
56,876
-120,089
-68% -$1.74M ﹤0.01% 4243
2018
Q4
$1.95M Sell
176,965
-70,075
-28% -$774K ﹤0.01% 3790
2018
Q3
$6.5M Buy
247,040
+37,970
+18% +$999K ﹤0.01% 2902
2018
Q2
$4.28M Buy
209,070
+42,600
+26% +$871K ﹤0.01% 3327
2018
Q1
$3.02M Sell
166,470
-25,719
-13% -$467K ﹤0.01% 3594
2017
Q4
$2.68M Buy
192,189
+27,069
+16% +$378K ﹤0.01% 3759
2017
Q3
$3.06M Buy
165,120
+20,553
+14% +$380K ﹤0.01% 3471
2017
Q2
$2.44M Sell
144,567
-129,157
-47% -$2.18M ﹤0.01% 3620
2017
Q1
$3.66M Buy
273,724
+28,069
+11% +$375K ﹤0.01% 3208
2016
Q4
$3.7M Buy
245,655
+177,260
+259% +$2.67M ﹤0.01% 3316
2016
Q3
$800K Buy
68,395
+5,829
+9% +$68.2K ﹤0.01% 4203
2016
Q2
$676K Buy
62,566
+6,524
+12% +$70.5K ﹤0.01% 4255
2016
Q1
$518K Sell
56,042
-13,717
-20% -$127K ﹤0.01% 4419
2015
Q4
$1.04M Buy
69,759
+38,470
+123% +$571K ﹤0.01% 4023
2015
Q3
$514K Buy
31,289
+4,928
+19% +$81K ﹤0.01% 4594
2015
Q2
$601K Sell
26,361
-204
-0.8% -$4.65K ﹤0.01% 4584
2015
Q1
$403K Sell
26,565
-371,142
-93% -$5.63M ﹤0.01% 4793
2014
Q4
$4.79M Sell
397,707
-56,123
-12% -$676K ﹤0.01% 2764
2014
Q3
$5.15M Buy
453,830
+414,922
+1,066% +$4.7M ﹤0.01% 2615
2014
Q2
$471K Sell
38,908
-159,648
-80% -$1.93M ﹤0.01% 4620
2014
Q1
$2.31M Buy
198,556
+29,833
+18% +$348K ﹤0.01% 3294
2013
Q4
$2.98M Buy
168,723
+24,043
+17% +$425K ﹤0.01% 3063
2013
Q3
$2.08M Buy
144,680
+115,713
+399% +$1.67M ﹤0.01% 3178
2013
Q2
$437K Buy
+28,967
New +$437K ﹤0.01% 4351